Rennova Health, Inc.(RNVA US)

$0.00+0.000.00%Ext:$0.00+0.000.00%(Market Closed · 20:00:00 UTC)

Summary

Rennova Health, Inc., through its various subsidiaries, provides medical services throughout the United States. As of December 31, 2021, the company's assets included an operational hospital situated in Oneida, Tennessee; an acute care facility and an associated doctor's practice located in Jamestown, Tennessee; and a rural medical clinic in Williamsburg, Kentucky. The organization was founded in 2005 and has its principal office in West Palm Beach, Florida.

Website

www.rennovahealth.com

Location

West Palm Beach, FL, US

Phone561 855 1626

Employees96

CEOSeamus Lagan

Sector

Consumer Staples

Industry

Personal Care Products

IPO DateOct 19, 1995

Ask AI

Company overview

Business model, segments, and competition.

Peer comparison

Metrics vs closest competitors.

Guidance & outlook

Forward guidance and assumptions.

Bull vs bear case

Upside drivers and key risks.

Valuation snapshot

Multiples vs history and peers.

Competitive moat

Defensibility and market position.

Management track record

Leadership and capital allocation history.

Latest Documents

Mentions in Filings

… O Technologies Inc., a Delaware corporation (the “**Company**,” “**we**,” “**us**,” or “**our**”), in connection with the corporate action described below taken by the Company’s Board of Directors (“**Board**”) and by Rennova Health, Inc. (which is controlled by the Company’s CEO), a shareholder representing a majority of the voting control of the Company (the “**Majority Shareholder**”). The Majority Shareholder, by written consent in lieu of a …
FOXO TECHNOLOGIES INC.Rennova Health, Inc.·DEF 14C - Definitive information statement·Q3 26·24 Aug
… O Technologies Inc., a Delaware corporation (the “**Company**,” “**we**,” “**us**,” or “**our**”), in connection with the corporate action described below taken by the Company’s Board of Directors (“**Board**”) and by Rennova Health, Inc. (which is controlled by the Company’s CEO), a shareholder representing a majority of the voting control of the Company (the “**Majority Shareholder**”). The Majority Shareholder, by written consent in lieu of a …
FOXO TECHNOLOGIES INC.Rennova Health, Inc.·PRE 14C - Preliminary information statement·Q3 26·14 Aug
… a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries. Myrtle and RCHI were acquired in 2024 from Rennova Health, Inc. (“RHI”). Vector was acquired in September 2025. *Segments* The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services, and (iii) Labs. Myrt …
FOXO TECHNOLOGIES INC.Rennova Health, Inc.·10-Q - Quarterly report Q2·Q2 26·14 Aug
On May 18, 2026, Rennova Health, Inc. (which is controlled by the Company’s CEO) (the “**Majority Stockholder**”), a shareholder representing a majority of the voting control of the Company, approved certain actions by written consent (the “**Written Consent**”). The Board of Directors of the Company fixed May 18, 2026 as the record date (the “**Record Date**”) for the determination of stockholders entitled to execute a written consent approving …
FOXO TECHNOLOGIES INC.Rennova Health, Inc.·8-K - Entry into a Material Definitive Agreement·Q2 26·22 May
… a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries. Myrtle and RCHI were acquired in 2024 from Rennova Health, Inc. (“RHI”). Vector was acquired in September 2025. *Segments* The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services, and (iii) Labs. Myrt …
FOXO TECHNOLOGIES INC.Rennova Health, Inc.·10-Q - Quarterly report Q1·Q1 26·15 May
… in returning the Company to good standing with its SEC reporting obligations, through November 2025. Most recently, from November 2025 until her appointment as Chief Financial Officer, Ms. Grant has been engaged with Rennova Health Inc., leading efforts to bring that company into compliance with SEC reporting requirements. Ms. Grant holds a Bachelor of Science in Accounting from Florida Atlantic University and a Master of Business Administratio …
FOXO TECHNOLOGIES INC.Rennova Health, Inc.·10-K - Annual report FY 2025·FY25·15 Apr

Key Stats

Trading

Px/Chg 1D$0.00 / +0.00%

Avg Volume1.07M

Beta-86.07

Mkt Cap4.31M

FD Mkt Cap4.31M

Float

Shrs Out/Float43.05B / 43.05B

Short Float0.00%

Days to Cover1.00

Stock Repurchased$0.00

Current Valuation

EV16.02M

EV/EBITDA11.05

EV/Sales0.86

P/B-0.12

P/S0.23

FCF Yield70.54%

ROE20.99%

ROA-38.16%

Current Ratio0.16

Estimates

P/E-0.56

Est P/EN/A

Est EPSN/A

Est PEGN/A

Valuation

Metric	5Yr Avg	Jul '20	Jun '21	May '22	May '23	Oct '26
PRICE-BASED RATIOS
Price / Earnings	-0.11	0.00	-0.00	0.00	-0.00	-0.56
Price / Sales	0.05	0.00	0.00	0.00	0.00	0.23
Price / Book Value	-0.02	0.00	-0.00	-0.00	-0.00	-0.12
Price / Free Cash Flow	0.28	0.00	-0.00	-0.00	-0.04	1.42
ENTERPRISE VALUE METRICS
Enterprise Value	25.2	57.9	22.0	15.4	14.6	16.0
Enterprise Value / Sales	2.68	3.62	3.06	4.76	1.12	0.86
Enterprise Value / EBITDA	-10.65	-2.41	-2.62	-12.15	-47.15	11.05
Enterprise Value / EBIT	-3.50	-2.33	-2.42	-8.05	-18.76	14.06

Financials

Full Financials

Millions USD	5Yr CAGR (%)	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
INCOME STATEMENT
Revenue	4%	16.0	7.2	3.2	13.0	18.7
Gross Income	123%	0.4	-4.6	-2.1	6.3	11.1
EBITDA	—	-24.1	-8.4	-1.3	-0.3	1.4
EBIT	—	-24.9	-9.1	-1.9	-0.8	1.1
Net Income	-36.7%	-48.0	-18.3	5.6	-3.3	-7.7
EPS (Diluted)	-99.9%	-3,077,380,701.32	-93,864,830.67	-913.37	-0.03	-0.00
BALANCE SHEET
Cash & ST Inv	30.4%	0.0	0.0	0.7	0.5	0.0
Total Assets	8.3%	14.7	12.3	19.6	20.6	20.3
Total Liabilities	-9.1%	83.6	61.3	46.9	49.7	57.1
Total Shareholder Equity	-14.5%	-68.9	-49.0	-27.3	-29.1	-36.8
CASH FLOW
Net Operating Cash Flow	—	-13.5	-16.9	-8.9	-0.2	3.4
Cap Ex	627.9%	-0.0	-0.4	-	-0.0	-0.4
Free Cash Flow	—	-13.5	-17.3	-8.9	-0.3	3.0

Enterprise Value Bridge

Millions USD		23 Oct '26
Price (As of 23 Oct '26)		0.00
Basic Shares		43,051.32
Market Cap		4.3
Diluted Shares		32,825.52
Fully Diluted Shares Outstanding		32,825.52
Fully Diluted Market Cap		3.3
+Consolidated Debt		11.8
−In-the-Money Convertible Debt		—
+Capital Leases		0.4
+Operating Leases		—
−Cash & Equivalents		-0.0
−Short-term Investments		-
+Total Preferred		0.0
−In-the-Money Convertible Preferred		—
−Investments in Unconsolidated Subs		—
+Non-Controlling Interest		-0.0
+Pension Liabilities		—
Enterprise Value		16.0

Rennova Health, Inc.(RNVA US)